Fang Christopher, Cornell Ella, Dicken Quinten, Freccero David, Mattingly David, Smith Eric L
New England Baptist Hospital, 125 Parker Hill Ave, Boston, 02120 MA, USA.
Boston Medical Center, One Boston Medical Center Pl, Boston, 02118 MA, USA.
SICOT J. 2020;6:37. doi: 10.1051/sicotj/2020035. Epub 2020 Sep 19.
As advances in efficacy of human immunodeficiency virus (HIV) and hepatitis-C virus (HCV) anti-viral medications increase, patients are able to maintain higher quality of lives than ever before. While these patients live longer lives, the unique patient population of those co-infected with both HIV and HCV increases. As these older patients seek orthopaedic care, it is important to understand their unique outcome profile. The purpose of this study was to evaluate the complication rate after total joint arthroplasty (TJA) in patients with HIV and HCV coinfection compared with patients with HIV or HCV only.
A retrospective review of patients undergoing primary total joint arthroplasty (TJA) at our urban, academic hospital between April 2016 and April 2019 was conducted. Patients were stratified into three groups according to viral status: HIV only, HCV only, or HIV and HCV coinfection. Baseline demographics, intravenous drug (IV) use, surgery type, CD4+ count, follow-up and complications were analysed.
Of the 133 patients included in the study, 28 had HIV, 88 had HCV and 17 were coinfected with both HIV and HCV. Coinfected patients were more likely to have a lower BMI (p < 0.039) and a history of IV drug use (p < 0.018) compared to patients with either HIV or HCV only. Coinfected patients had a higher complication rate (41%) than both HIV only (7%; p < 0.001) and HCV only (12.5%; p < 0.001) patients.
Patients coinfected with HIV and HCV undergoing TJA have a higher complication rate than patients with either infection alone. As this unique population of coinfected patients continues to expand, increasingly they will be under the care of arthroplasty surgeons. Improved awareness and understanding of the baseline demographic differences between these patients is paramount. Recognition of the increased complication rates grants the opportunity to improve their orthopaedic care through preoperative and multidisciplinary management.
随着人类免疫缺陷病毒(HIV)和丙型肝炎病毒(HCV)抗病毒药物疗效的提高,患者能够维持比以往更高的生活质量。虽然这些患者寿命延长,但同时感染HIV和HCV的独特患者群体也在增加。随着这些老年患者寻求骨科治疗,了解他们独特的预后情况很重要。本研究的目的是评估与仅感染HIV或HCV的患者相比,HIV和HCV合并感染患者全关节置换术(TJA)后的并发症发生率。
对2016年4月至2019年4月在我们城市的学术医院接受初次全关节置换术(TJA)的患者进行回顾性研究。根据病毒感染状况将患者分为三组:仅感染HIV、仅感染HCV或同时感染HIV和HCV。分析了基线人口统计学、静脉药物使用情况、手术类型、CD4 +细胞计数、随访情况和并发症。
在纳入研究的133例患者中,28例感染HIV,88例感染HCV,17例同时感染HIV和HCV。与仅感染HIV或HCV的患者相比,合并感染患者的BMI较低(p < 0.039)且有静脉药物使用史的可能性更大(p < 0.018)。合并感染患者的并发症发生率(41%)高于仅感染HIV的患者(7%;p < 0.001)和仅感染HCV的患者(12.5%;p < 0.001)。
接受TJA的HIV和HCV合并感染患者的并发症发生率高于仅感染其中一种病毒的患者。随着这一独特的合并感染患者群体不断扩大,他们将越来越多地接受关节置换外科医生的治疗。提高对这些患者之间基线人口统计学差异的认识和理解至关重要。认识到并发症发生率的增加为通过术前和多学科管理改善他们的骨科治疗提供了机会。